Tuesday 15 February 2022

Big broad-based gains for Covid Vaccine Stocks - Immunity Bio jumps 22%


Rocketing upwards on February 15. A real strong broad-based move upwards lead by Immunity Bio which moved up 22%. There were fully 24 winners and only three losers today. 

The next strongest gainers were Novavax and Vaxart with 9% gains.

Vir, Ocugen and VBI all picked up 7%. 



 

No comments:

Post a Comment